glp-1 receptor agonist function agonists show promise in treating substance use disorders GLP-1 Agonists - What is
Description
Patients with established cardiovascular disease should receive a pharmacological treatment intensification with an agent that has demonstrated benefit in cardiovascular safety studies: In patients with pre-existing atherosclerotic cardiovascular disease (ASCVD), a GLP-1 receptor agonist, or SGLT-2 inhibitor with characterized cardiovascular safety should be used
doi: 10.1111/dom.15896 78 HuangYNLiaoWLHuangJYLinYJYangSFHuangCCet al
The American journal of clinical nutrition
It also slows the emptying of the stomach, enhancing the sensation of fullness after meals
Many patients who initially struggle with side effects tolerate the medication well after adjustments to their escalation schedule
